Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2001-12-25
pubmed:abstractText
Defective DNA mismatch repair (MMR) appears to be rare in nonsmall cell carcinomas of the lung. Defective DNA MMR results from genetic or epigenetic alterations that inactivate the DNA MMR genes hMLH1 or hMSH2, and rarely hMSH6. The loss of normal DNA MMR is thought to promote tumorigenesis by accelerating the accumulation of mutations in oncogenes and tumor suppressor genes. Inactivation of hMLH1, hMSH2, and hMSH6 is observed as a loss of expression of these proteins by immunohistochemistry. Bronchioloalveolar carcinoma is a subtype of adenocarcinoma with distinctive clinical and pathologic features.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0008-543X
pubmed:author
pubmed:copyrightInfo
Copyright 2001 American Cancer Society.
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2898-901
pubmed:dateRevised
2010-3-24
pubmed:meshHeading
pubmed-meshheading:11753964-Adaptor Proteins, Signal Transducing, pubmed-meshheading:11753964-Adenocarcinoma, Bronchiolo-Alveolar, pubmed-meshheading:11753964-Aged, pubmed-meshheading:11753964-Aged, 80 and over, pubmed-meshheading:11753964-Base Pair Mismatch, pubmed-meshheading:11753964-Carrier Proteins, pubmed-meshheading:11753964-DNA Repair, pubmed-meshheading:11753964-DNA-Binding Proteins, pubmed-meshheading:11753964-Female, pubmed-meshheading:11753964-Humans, pubmed-meshheading:11753964-Immunohistochemistry, pubmed-meshheading:11753964-Lung Neoplasms, pubmed-meshheading:11753964-Male, pubmed-meshheading:11753964-Middle Aged, pubmed-meshheading:11753964-MutS Homolog 2 Protein, pubmed-meshheading:11753964-Neoplasm Proteins, pubmed-meshheading:11753964-Nuclear Proteins, pubmed-meshheading:11753964-Proto-Oncogene Proteins
pubmed:year
2001
pubmed:articleTitle
DNA mismatch repair genes hMLH1, hMSH2, and hMSH6 are not inactivated in bronchioloalveolar carcinomas of the lung.
pubmed:affiliation
Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA. aubry.mariechristine@mayo.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't